CLDN1 and neoplasm: However, research has also shown that CLDN1 could exert tumor promoter characteristics by increasing the invasion or motility of cancer cells, which could decrease the efficacy of our cancer vaccine (Chao et al., 2009; Sun et al., 2016; Bhat et al., 2020).